DE60022070D1 - Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen - Google Patents

Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen

Info

Publication number
DE60022070D1
DE60022070D1 DE60022070T DE60022070T DE60022070D1 DE 60022070 D1 DE60022070 D1 DE 60022070D1 DE 60022070 T DE60022070 T DE 60022070T DE 60022070 T DE60022070 T DE 60022070T DE 60022070 D1 DE60022070 D1 DE 60022070D1
Authority
DE
Germany
Prior art keywords
treatment
nitrogen oxide
respiratory airways
airways
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60022070T
Other languages
English (en)
Other versions
DE60022070T2 (de
Inventor
Josephine Hjoberg
Goeran Hedenstierna
Marieann Hoegman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INO Therapeutics LLC
Original Assignee
AGA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGA AB filed Critical AGA AB
Application granted granted Critical
Publication of DE60022070D1 publication Critical patent/DE60022070D1/de
Publication of DE60022070T2 publication Critical patent/DE60022070T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60022070T 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen Expired - Lifetime DE60022070T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
SE9903985 1999-11-03
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (2)

Publication Number Publication Date
DE60022070D1 true DE60022070D1 (de) 2005-09-22
DE60022070T2 DE60022070T2 (de) 2006-03-30

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022070T Expired - Lifetime DE60022070T2 (de) 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen

Country Status (20)

Country Link
EP (1) EP1225913B8 (de)
JP (1) JP2003513048A (de)
CN (1) CN1230199C (de)
AR (1) AR026335A1 (de)
AT (1) ATE302023T1 (de)
AU (1) AU778347B2 (de)
BR (1) BR0015329A (de)
CA (1) CA2389655A1 (de)
CZ (1) CZ20021559A3 (de)
DE (1) DE60022070T2 (de)
EE (1) EE200200240A (de)
ES (1) ES2248153T3 (de)
HU (1) HUP0203065A3 (de)
IL (1) IL149170A0 (de)
MX (1) MXPA02004069A (de)
NO (1) NO20022113D0 (de)
PL (1) PL354653A1 (de)
SE (1) SE9903985D0 (de)
WO (1) WO2001032202A1 (de)
ZA (1) ZA200203391B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2004000368A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CA2745411A1 (en) * 2008-12-03 2010-06-10 Ltt Bio-Pharma Co., Ltd. Inhalant containing modified superoxide dismutase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE560928T1 (de) * 1990-12-05 1994-09-22 Gen Hospital Corp Vorrichtung zum behandeln einer lungengefässverengung und von asthma.
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
HUP0203065A2 (hu) 2003-01-28
EE200200240A (et) 2003-06-16
AR026335A1 (es) 2003-02-05
HUP0203065A3 (en) 2006-07-28
DE60022070T2 (de) 2006-03-30
EP1225913B1 (de) 2005-08-17
NO20022113L (no) 2002-05-02
BR0015329A (pt) 2002-07-09
NO20022113D0 (no) 2002-05-02
CN1230199C (zh) 2005-12-07
MXPA02004069A (es) 2003-08-20
AU778347B2 (en) 2004-12-02
JP2003513048A (ja) 2003-04-08
CN1387441A (zh) 2002-12-25
EP1225913A1 (de) 2002-07-31
CZ20021559A3 (cs) 2003-05-14
AU1745601A (en) 2001-05-14
ES2248153T3 (es) 2006-03-16
ZA200203391B (en) 2002-12-20
ATE302023T1 (de) 2005-09-15
SE9903985D0 (sv) 1999-11-03
IL149170A0 (en) 2002-11-10
CA2389655A1 (en) 2001-05-10
PL354653A1 (en) 2004-02-09
WO2001032202A1 (en) 2001-05-10
EP1225913B8 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE246500T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
ATE399541T1 (de) Epidermale wachstumsfaktor rezeptor antagonisten zur behandlung stark vermehrter schleimsekretion in der lunge
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
DE60140377D1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60319865D1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ATE538096T1 (de) Pyridinon-derivate zur behandlung von arteriosklerose
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60022070D1 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: AGA AB, LIDINGOE, SE

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INO THERAPEUTICS LLC, CLINTON, N.J., US